Company / Cash & Equivalents
AETERNUM HEALTH, INC. Cash & Equivalents History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
-
FY2025
5-year range
$0 / $416
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Remained stable around $0 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak cash & equivalents was recorded in FY2014.
Company context
Key Data Points
- Altman Z-Score -77.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | - |
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2018 | $330 | -20.7% |
| FY2016 | $416 | -32.2% |
| FY2015 | $614 | -94.4% |
| FY2014 | $11.0K | +127.1% |
| FY2012 | $4.8K | +96.1% |
| FY2011 | $2.5K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026